CSF3 and neutropenia: This is notable, because theincidence of grade 3 or 4 neutropenia was comparable to rates in other publishedstudies despite the lack of granulocyte colony-stimulating factor support.30-32 When we included planned chemotherapy, the proportion ofpatients receiving a relative dose-intensity greater than 0.85 was comparable torates in recent reports in North America and superior to rates from the1990s.34,35 Receipt of endocrine therapy was also high.